Relatively smaller deals are having their best start to the year since the 2021 pandemic-era, and sectors such as pharma are ...
Deals exceeding $10 billion are down about 28% for the quarter, but mid-range acquisitions valued from $1 billion to $10 billion are up 38% compared to the same period last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results